Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Acta Oncol. 2019 Oct 12;59(2):164–170. doi: 10.1080/0284186X.2019.1675907

Table 3-.

Univariable and Multivariable Cox Regression Analyses Predicting OS:

Univariable Multivariable
N = 6490 HR 95% CI p-value HR 95% CI p-value
HFRT vs CFRT 1.14 1.06, 1.22 <0.001 1.08 1.01, 1.16 0.027
Increasing Age 1.01 1.01, 1.01 <0.001 1.01 1.01, 1.01 <0.001
Increasing BED 0.98 0.98, 0.99 <0.001 0.98 0.98, 0.99 <0.001
Miles from hosp. 1.00 1.00, 1.00 0.2
Sex (Female vs Male) 0.83 0.79, 0.87 <0.001 0.83 0.79, 0.88 <0.001
Race (White vs Other) 1.09 1.02, 1.18 0.018 1.03 0.95, 1.11 0.5
Insurance (Medicare vs Other) 1.24 1.17, 1.32 <0.001 1.14 1.07, 1.23 <0.001
Urban (Pop. >1 million) 0.91 0.86, 0.96 <0.001 0.91 0.86, 0.96 <0.001
Facility Type (Academic vs Other) 0.89 0.84, 0.95 <0.001 0.92 0.86, 0.97 0.004
CDCC_TOTAL
 0 Ref. Ref.
 1 1.10 1.03, 1.16 0.003 1.09 1.02, 1.15 0.007
 2 1.20 1.10, 1.31 <0.001 1.19 1.09, 1.30 <0.001
 3 1.32 1.16, 1.50 <0.001 1.33 1.17, 1.51 <0.001
Year of Diagnosis >2009 0.91 0.86, 0.96 <0.001 0.88 0.84, 0.93 <0.001
Tumor location (Upper vs Lower) 0.84 0.79, 0.88 <0.001 0.84 0.80, 0.89 <0.001
Histology
 Squamous Ref. Ref.
 Adeno 0.83 0.78, 0.88 <0.001 0.89 0.84, 0.95 <0.001
 Other 0.97 0.91, 1.03 0.3 0.99 0.93, 1.06 0.8
T-stage 3/4 1.17 1.11, 1.23 <0.001 1.34 1.26, 1.42 <0.001
N-stage 2/3 1.10 1.03, 1.17 0.003 1.33 1.24, 1.43 <0.001
Location
 East Coast Ref.
 Central 1.03 0.98, 1.09 0.2
 West Coast 0.97 0.89, 1.05 0.4
Tumor laterality (Right vs Left) 0.98 0.93, 1.03 0.4
Grade
 Well/mod Ref.
 Poor 1.03 0.96, 1.11 0.4
 Not determined 0.97 0.91, 1.04 0.4
Median Income <$38K 0.98 0.92, 1.04 0.5
Education (No HSD vs other) 0.94 0.88, 1.01 0.084

Univariable (UVA) Hazard Ratio (HR), 95% Confidence Interval (CI), and p-value calculated by univariable Cox proportional hazards regression with an endpoint of overall survival. Multivariate (MVA) OR, 95% CI and p-value calculated by using multivariable Cox proportional hazards regression with an endpoint of overall survival, adjusting for all variables that were significant in the UVA model. HFRT = Hypofractionated Radiotherapy, CFRT = Conventional Radiotherapy, BED = Biologic Effective Dose, HSD = High School Diploma, CDCC = Charlson Deyo Comorbidity Index